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Abstract
Objectives—Acute hepatitis B virus (HBV) infections have been reported in long-term care 
facilities (LTCFs) primarily associated with infection control breaks during assisted blood glucose 
monitoring. We investigated HBV outbreaks that occurred in separate skilled nursing facilities 
(SNFs) to determine factors associated with transmission.
Design—Outbreak investigation with case-control studies.
Setting—Two SNFs (Facility A and B) in Durham, North Carolina during 2009–2010.
Patients—Residents with acute HBV infection and controls randomly selected from HBV-
susceptible residents during the outbreak period.
Methods—After initial cases were identified, screening was offered to all residents with repeat 
testing three months later for HBV-susceptible residents. Molecular testing was performed to 
assess viral relatedness. Infection control practices were observed. Case-control studies were 
conducted to evaluate associations between exposures and acute HBV infection in each facility.
Results—Six acute HBV cases were identified in each SNF. Viral phylogenetic analysis revealed 
a high degree of HBV relatedness within, but not between, facilities. No evaluated exposures were 
significantly associated with acute HBV infection in Facility A; those associated with infection in 
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Facility B (all odds ratios>20) included injections, hospital or emergency room visits, and daily 
blood glucose monitoring. Observations revealed absence of trained infection control staff at 
Facility A, and suboptimal hand hygiene practices during blood glucose monitoring and insulin 
injections at Facility B.
Conclusions—These outbreaks underscore the vulnerability of LTCF residents to acute HBV 
infection, the importance of surveillance and prompt investigation of incident cases, and the need 
for improved infection control education to prevent transmission.
Despite the decline in incidence of acute hepatitis B virus (HBV) infection in the United 
States since the 1980s,1 increasing reports of HBV outbreaks among persons residing in 
assisted living and skilled nursing facilities (SNFs) have generated growing concern and 
resulted in Advisory Committee on Immunization Practice recommendations for HBV 
vaccination of diabetics.2 During 1996–2011, 30 outbreaks of acute HBV infection were 
reported among residents of US long-term care facilities (LTCFs).3–4 Of these, 25 (86%) 
were associated with breaks in infection control practices during assisted blood glucose 
monitoring, one during podiatry care, and one with behavioral risks.3 These outbreaks 
require considerable expenditure of financial and personnel resources at the LTCFs and 
health departments conducting the investigations. More importantly, they resulted in 
preventable illnesses and deaths among residents. The risk of progression to chronic 
infection from acute HBV infection is higher among the elderly than younger adults,5 and 
mortality rates as high as 75% have been reported in recent LTCF outbreaks.6
During October 2009 – June 2010, we identified two outbreaks of acute HBV infection 
through investigation of individual cases among residents of separate SNFs in Durham, 
North Carolina. We conducted epidemiologic investigations of these outbreaks to identify 
additional cases and potential modes of HBV transmission.
METHODS
Investigations were conducted by the Durham County Department of Public Health 
(DCoDPH), the North Carolina Department of Health and Human Services (NC DHHS), 
and the Centers for Disease Control and Prevention (CDC). All aspects of the investigation 
were considered part of a public health response and determined to be exempt from 
Institutional Review Board approval.
Case Finding
The first acute HBV case in Facility A was reported to DCoDPH in July 2009. Three 
additional cases among residents of the same SNF were reported during October – 
December, 2009. In January 2010, HBV screening was performed on all consenting 
residents with unknown HBV status. Serologic testing was repeated in April 2010 for HBV 
susceptible residents to identify new infections that might have been undetectable during 
initial screening.7
The first acute HBV case in Facility B was reported to DCoDPH in April 2010. After 
additional cases were identified by targeted screening of residents with shared exposures, 
Seña et al. Page 2













HBV screening of all consenting residents with unknown HBV status was performed in June 
2010 with repeat testing in September 2010.
Laboratory Methods
All specimens were initially tested for HBsAg (Bio-Rad GS HBsAg EIA 3.0), anti-HBs, and 
anti-HBc (Bio-Rad MONOLISA™) qualitatively at the NC State Laboratory of Public 
Health using BioRad Evolis analyzers. Specimens that tested positive for total anti-HBc 
were tested for IgM anti-HBc (Bio-Rad MONOLISA™). Serum samples from residents 
identified with acute or chronic HBV infection were sent to CDC’s Viral Hepatitis 
Reference Laboratory for additional qualitative testing for anti-HBc (VITROS® aHBc), IgM 
anti-HBc (VITROS® HBcM), and HBsAg (VITROS® HBsAg). These specimens were also 
tested quantitatively for anti-HBs (VITROS® anti-HBs) using automated VITROS® 
Immunodiagnostic system (Ortho-Clinical Diagnostics, Inc., Rochester, NY).
Serum samples with a positive HBsAg result were sent to the CDC’s Molecular 
Epidemiology and Bioinformatics Laboratory for HBV sequence analysis. HBV DNA was 
extracted from 100 µL of serum. The entire HBV genome was amplified by nested 
polymerase chain reaction, and the sequences were compared to determine the genetic 
relatedness of HBsAg positive samples as previously described.8 In specimens with viral 
titers insufficient to obtain full HBV genome, a 425 base-pair fragment of the HBV “S” gene 
region was sequenced to determine HBV genotype.
Case-Control Studies
Separate case-control studies were performed in each facility to evaluate exposures 
associated with acute HBV infection. We defined HBV infection and HBV susceptibility 
status based on laboratory criteria (Table 1). Facility medical records and laboratory data 
were reviewed for each case to determine the most likely date of disease onset. Disease 
onset date was defined as either the earliest date on which HBsAg or IgM anti-HBc was 
detected, or on which jaundice or alanine aminotransferase levels >2 times the upper limit of 
normal was detected in the absence of another etiology. For each acute HBV case, four 
controls were randomly selected among residents of the same facility who were HBV-
susceptible and had resided in the facility throughout the case’s exposure period, defined as 
six months to six weeks prior to disease onset date.6 Facility medical records were reviewed 
for each control to evaluate potential source exposures during the case’s exposure period.
Medical record abstractions were performed using the same data collection form in both 
facilities. This form included demographic information, clinical history, room assignments, 
and potential healthcare exposures including blood glucose monitoring, podiatry care, 
hospitalizations or emergency room (ER) visits, outpatient invasive procedures, dental care, 
wound care, and phlebotomy.
Data Analysis
Basic demographic characteristics and exposures with the potential for HBV transmission 
were compared among cases and controls using two-tailed Wilcoxon signed rank sum tests 
for continuous variables and Mantel-Haenzel chi-square tests for dichotomous variables. 
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Fisher’s exact test was used to assess variables with small numbers of observations (< 5). 
Healthcare exposures were only included in the analyses if they occurred during the 
exposure period for cases or the corresponding time period for controls. To assess whether 
the frequency of certain healthcare exposures was associated with acute HBV infection, we 
collected data on the number of days of blood glucose monitoring, injections, wound care, 
and phlebotomy for cases and controls. All analyses were performed in SAS version 9.2 
(SAS Institute, Cary, NC).
Infection Control Observations
On-site services were observed at each SNF to assess for potential percutaneous exposures, 
including podiatry, ophthalmology, phlebotomy, dentistry, physical and occupational 
therapy, and beautician and barber services. Blood glucose monitoring, insulin preparation 
and administration, and wound care procedures were observed on multiple days and at 
different times. Information regarding infection control procedures was gathered through 
staff interviews. Infection control policy manuals, needlestick injury protocols, and staff 
HBV vaccination status were reviewed.
RESULTS
Case Finding and Clinical Characteristics
Initial and repeat serologic HBV screening results are summarized for each SNF in Figure 1. 
Six cases with acute HBV infection and one case with previously known chronic hepatitis B 
infection were identified from each facility, for a total of 12 acute HBV cases (6%) among 
209 residents tested for HBV. No additional acute or chronic HBV infections were identified 
during repeat screening. Serologic testing at CDC confirmed the status of 11 acute HBV-
infected cases; one patient died before a specimen could be obtained for CDC testing.
Three cases had jaundice with or without other symptoms at Facility A; the other three cases 
at Facility A and all six cases at Facility B had no symptoms attributable to acute HBV 
infection. Three patients from Facility A died within two months of diagnosis; one death 
was attributed to HBV infection. No deaths attributable to HBV infection were identified 
among patients from Facility B. One of three surviving patients at Facility A and three of six 
patients at Facility B developed chronic HBV infection.
Molecular Analysis
Phylogenetic testing of the specimens from Facility A revealed that virus from all acute 
cases and the resident with chronic infection were HBV genotype A2, with an identical 
425bp segment of the ‘S’ gene. A full HBV genome could be isolated from four acute cases 
and the patient with chronic infection; all five specimens shared a high degree of nucleotide 
identity (99.7–100%) (Figure 2). Sequences from two cases who had been roommates had 
100% genetic identity across the full genome. Phylogenetic testing of Facility B specimens 
revealed that HBV from all six acute cases were genotype A2 and shared a high degree of 
genetic identity (99.9–100%) across the full genome (Figure 2). A comparison of HBV 
phylogenetic sequences between the two clusters indicated a low degree of genetic identity, 
suggesting that the clusters were not related.
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Case-Control Study, Facility A
There were no significant differences in age, gender, race, or co-morbid conditions between 
cases and controls in Facility A (Table 2). Five cases and 11 controls had chronic renal 
insufficiency; however, none were receiving dialysis.
There were no statistically significant differences in healthcare exposures between cases and 
controls (Table 2). Among three cases who had been exposed to assisted blood glucose 
monitoring, one received daily fingersticks, another received twice weekly fingersticks, and 
a third case received blood glucose monitoring only once during the exposure period. A 
review of hospital and ER visits showed that none of the cases or the resident with chronic 
infection had visits to the same facility during overlapping time periods.
Cases had more frequent exposure to onsite phlebotomy, with a median of 15 days during 
the exposure period (range 3–49) compared to 4 days (range 0–42) for controls (Table 3); 
however, this difference was not statistically significant (p=0.08). There were no significant 
differences between cases and controls with respect to median days of wound care, blood 
glucose monitoring, or onsite injections during the exposure period.
Case-Control Study, Facility B
There were no significant differences in age, gender, race, or co-morbid conditions between 
cases and controls in Facility B (Table 1). Only two of the cases and seven of the controls 
had been diagnosed with diabetes. One case and four controls had renal insufficiency, but 
none were on dialysis.
Although there was no exposure shared by all cases, several healthcare exposures were 
significantly associated with acute HBV infection in Facility B (Table 2). Cases had more 
frequent exposure to assisted bloodblood glucose monitoring, with four out of six cases 
receiving daily fingersticks versus only two out of 24 controls. Although having had any 
exposure to blood glucose monitoring was not significantly associated with acute HBV 
infection, daily blood glucose monitoring was significantly associated (OR 22.0; 95% CI: 
2.4–204.1). Having had a hospital/ER visit also was strongly associated with acute HBV 
infection (OR 22.0; 95% CI: 2.4–204.1); however, none of the cases or the resident with 
chronic infection had hospitalizations or ER visits at the same facility during overlapping 
time periods. In addition to more frequent blood glucose monitoring, cases also had more 
frequent exposure to phlebotomy and injected medications (including insulin) as compared 
to controls (P=0.05 and <0.01, respectively) (Table 3).
Assessment of Behavioral Risk Factors
Staff and administrators in both SNFs denied any knowledge of sexual activity, elder abuse 
or injection drug use among the patients. Case interviews were conducted but were limited 
in some instances due to dementia. All cases required skilled nursing care and were too 
debilitated to leave the facility without assistance.
Only two of the cases had resided in the same room at Facility A during the likely exposure 
period. None of the cases from Facility B had been roommates during their exposure 
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periods. No other cases shared a room or common bathroom with each other, although 
sharing of shower rooms was possible.
Infection Control Assessment
Although both facilities had written infection control policies in place, Facility A was not in 
compliance with a North Carolina administrative code rule requiring that an on-site staff 
member be designated to direct infection control activities and complete a state-approved 
infection control course.9
Infection control observations revealed that staff members did not consistently perform hand 
hygiene between patients during blood glucose monitoring and insulin injections at Facility 
B. Both facilities used single-use, auto-disabling fingerstick devices. Blood glucometers 
were shared among multiple residents, but were cleaned and disinfected according to 
manufacturer’s instructions after every use. No sharing of insulin or injection supplies was 
identified.
Staff at Facility A voiced concerns about the infection control practices of the contracted 
phlebotomy service provider, who was shared by both facilities. Observations and a review 
of practices by this provider revealed several areas that needed attention including placing 
used gloves in contact with clean supplies and failing to consistently perform hand hygiene 
between patients. No lapses in infection control that would have facilitated bloodborne 
pathogen transmission were witnessed during observations of other services, including 
wound care, physical therapy, occupational therapy, dentistry, and podiatry.
Hepatitis B Vaccinations
Only twelve residents at each SNF had serologic evidence of previous hepatitis B 
vaccination (Figure 1). At Facility A, 72% of 104 staff members employed during July 2010 
had received hepatitis B vaccination; at Facility B, 65% of 69 staff members who were 
involved in direct patient care during May 2010 had received hepatitis B vaccination. During 
the investigation, hepatitis B vaccinations were recommended for previously unvaccinated 
staff involved in direct patient care, and combined hepatitis A/B vaccinations were provided 
to susceptible residents at both SNFs after the initial HBV screening.10
DISCUSSION
We describe two outbreaks of acute HBV infection in separate SNFs located within the same 
geographical area during the same time period. In Facility A, we did not find a significant 
association between acute HBV infection and any healthcare exposures. The second 
outbreak at Facility B was strongly associated with several exposures including blood 
glucose monitoring and insulin injections, but there was no single exposure shared by all 
cases. We found no evidence indicating that the two outbreaks were related and no common 
modes of transmission were identified between facilities.
Both laboratory and provider reporting of acute HBV cases are essential for viral hepatitis 
surveillance and early outbreak detection. This outbreak illustrates the challenges in 
recognizing acute HBV infections among SNF residents, since most cases in the elderly are 
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asymptomatic11 and do not meet the national case definition for acute infection requiring 
signs and symptoms.12 This report also illustrates an outstanding example of cooperation 
between local, state, and federal partners, in which prompt recognition and investigation of 
all incident HBV infections reported among LTCF residents was important for preventing 
HBV transmission. The CDC has developed recommendations for the investigation of single 
cases of viral hepatitis infection suspected to be associated with healthcare delivery,13,14 
which may provide a useful framework for health departments in developing an approach to 
investigations that fits their resources.
Determining whether these two outbreaks were directly linked was a major concern initially, 
given their close proximity in time and space and the use of shared ancillary service 
providers. Full-genome viral phylogenetic analysis was important in identifying two distinct 
clusters likely due to HBV transmission within the facilities, but not between facilities, in 
contrast to recent outbreaks in other states.3 HBV genotype A2 is common (about 80% of 
US isolates)15 and relatively homogeneous. Genetic homology of < 99.9% may not provide 
definitive evidence for a direct transmission link in the absence of epidemiologic evidence 
suggesting such transmission. However, phylogenetic clustering of HBV variants according 
to facilities, with isolates from two roommate cases at Facility A and five cases at Facility B 
having 100% genetic identity, suggest that direct transmission within facilities was very 
likely.
Unlike prior reports of acute HBV outbreaks, which have been primarily observational or 
retrospective cohort studies, we conducted separate case-control studies in which controls 
had to have resided in the facility throughout the cases’ exposure periods. This method 
allowed us to conduct chart reviews on a smaller number of residents as compared to a full 
cohort study, and reduced the possibility for bias introduced by comparing cases and 
controls who did not share the same healthcare exposures.
While most previous reports have linked HBV outbreaks in LTCFs to one predominant mode 
of transmission- usually unsafe practices during blood glucose monitoring- our findings 
suggest that multiple modes of transmission may be involved in these outbreaks. It is also 
possible that transmission in these facilities occurred through exposures other than those we 
analyzed. While we did not ascertain HBV status among unvaccinated staff, healthcare 
worker-to-patient transmission is unlikely as these events have been documented only during 
certain invasive procedures (e.g. cardiothoracic surgery).16 No controlled substances for 
injection administration (e.g. narcotics) were stored at the facilities, so contamination of 
medication vials or needles/syringes by staff practicing illicit drug use was unlikely. A 
confidential survey of staff conducted at Facility A and in-person case interviews in both 
facilities (data not shown) did not identify any behavioral risks for transmission, such as 
sexual contact between cases and staff members.
Our investigation was subject to several limitations. Interpretation of our data was limited by 
the small number of acute HBV cases. Also, data were collected primarily from medical 
records and provider interviews; information obtained from case interviews was limited due 
to dementia. Our results could have been biased if the assessment of cases’ onset dates and 
exposure periods was incorrect, particularly in Facility B where the majority of cases were 
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asymptomatic. In absence of symptoms, we defined the disease onset date as the time that 
testing was performed; therefore, we may have abstracted information on exposures that 
occurred after the cases had already acquired HBV infection. Finally, it is possible that 
infection control breaches had been corrected prior to our investigation or were not apparent 
during our observations. Breaches may be intermittent, particularly if healthcare providers 
are aware of proper technique but lapse when distracted or busy.17 Knowledge that an 
investigation is underway might also lead to immediate changes in unsafe practices.
There have been numerous reports of acute HBV infection outbreaks associated with 
assisted bloodblood glucose monitoring among residents in assisted living facilities6,18–22 
and SNFs.18,23 Although the role of blood glucose monitoring in our outbreaks is unclear, 
hand hygiene was not consistently practiced between residents who had assistedblood 
glucose monitoring or insulin injections at Facility B, and glucometers were shared between 
residents at both facilities. Guidance on infection control practices during blood glucose 
monitoring and insulin administration has been recently updated.24 The adoption of these 
preventive measures, along with hepatitis B vaccination of diabetic patients,2 are critical to 
reducing the risk of HBV transmission in LTCFs.
These outbreaks underscore the continued vulnerability LTCF residents to HBV and suggest 
that transmission may occur through multiple modes during a single outbreak. Coordinated 
efforts between local, state, and federal partners utilizing both traditional and molecular 
epidemiologic methods may be necessary to fully assess potential healthcare exposures. 
Improving patient safety in LTCFs will require a multifaceted strategy that incorporates 
improved recognition and prompt investigation of incident HBV infections among residents, 
HBV vaccinations for diabetic residents, and improved infection control education for LTCF 
staff.
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Figure 1. Hepatitis B screening results from Facility A and Facility B.1
1See Table 1 for definitions,
2These patients represented the acute cases of HBV infection detected in each facility during 
the outbreak investigation.
3 Seventeen patients from the two facilities had unclear serologic results. Of these, 15 
patients had isolated positive anti-HBc with anti-HBs and all other markers negative, 1 had a 
(+) HBcAb and (+) anti-HBs (without documented vaccination status) and 1 had a (+) anti-
HBs only.
Isolated positive core antibody may indicate a false positive result, low-level chronic 
infection with low level of infectivity, or most commonly in elderly populations past 
infection with waning immunity.12
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Figure 2. Hepatitis B virus phylogenetic analysis tree
Phylogenetic testing analysis of specimens from Facility A revealed that five acute cases and 
one resident with chronic infection had HBV genotype A2 with an identical 425bp segment 
of the ‘S’ gene. Isolation of the full HBV genome from four of the acute cases and the 
patient with chronic infection revealed a high degree of nucleotide identity (99.7–100%). 
From Facility B, phylogenetic testing analysis from all six acute cases also identified HBV 
genotype A2 and a high degree of genetic identity (99.9–100%) across the full genome.
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Table 1
Laboratory criteria for hepatitis B virus case classifications.




Acute hepatitis B infection (+) (+) (+) (−)
Chronic hepatitis B infection (+) (+) (−) (−)
Previous hepatitis B infection (−) (+) (−) (+)
Immunity to hepatitis B infection due to vaccination (−) (−) (−) (+)
Susceptible to hepatitis B infection (−) (−) (−) (−)
HBsAg = hepatitis B surface antigen
IgM anti-HBc = IgM antibodies to hepatitis B core antigen
anti-HBc = antibodies to hepatitis B core antigen
anti-HBs = positive hepatitis B antibody
*
Very early acute infection may present with positive HBsAg but negative anti-HBc and negative IgM anti-HBc, and subsequent development of 
anti-HBc.









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Infect Control Hosp Epidemiol. Author manuscript; available in PMC 2017 November 07.
